Selenium supplementation for critically ill adults

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  Allingstrup, Mikkel ^a   Afshari, Arash ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EBSELEN; SELENIUM; SODIUM SELENITE; ANTIOXIDANT; ORGANOSELENIUM DERIVATIVE; PYRROLE DERIVATIVE;

ALL CAUSE MORTALITY; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; FEVER; HUMAN; LENGTH OF STAY; MENINGITIS; MORTALITY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; META ANALYSIS; MORTALITY;

ADULT; ANTIOXIDANTS; AZOLES; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; HUMANS; ORGANOSELENIUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM SELENITE;

EID: 84957409721     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003703.pub3     Document Type: Review

References (98)

1. Angstwurm MWA, Schopohl J, Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. European Journal of Endocrinology 2004;151(1):47-54. [MEDLINE: PMID: 15248821]
2. Angstwurm MWA, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Critical Care Medicine 1999;27(9):1807-13. [MEDLINE: PMID: 10507602]
3. Gärtner R, Angstwurm MWA, Schopohl J. Selenium replacement in patients with SIRS improves clinical outcome. Clinical Nutrition 2002;21(Suppl 1):66.
4. Gärtner R, Angstwurm MWA, Schottdorf J. Selenium administration in sepsis patients. Medizinische Klinik 1997;92(Suppl 3):12-4. [PUBMED: 9417486]
5. Angstwurm MW, Englemann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Critical Care Medicine 2007;35(1):118-26.
6. Angstwurm MWA, Gaertner R. Selenium substitution in severe sepsis as useful additive? Preliminary results of the SIC study. Intensive Care Medicine 2005;31(Suppl 1):S84.
7. Forceville X. The need for precise dose information of sodium selenite in the SIC study and rectification of GPx-3 plasma concentration. Critical Care Medicine 2008;36(2):656-7.
8. Forceville X. The need for precise dose information of sodium selenite in the SIC study and rectification of GPx-3 plasmaconcentration. Erratum. Critical Care Medicine 2008;36(7):2224.
9. Gaertner R. Sodium selenite as an adjunctive therapy for sepsis - clinical data from a multi-centre intervention study (SIC Study). DIVI Congress, Hamburg, Symposium 'Adjunctive therapy in sepsis: what has been confirmed?'. 4 December 2004.
10. Schomburg L. Selenium in Intensive Care (SIC) study: the XX files are still unresolved. Critical Care Medicine 2007;35(3):995-6.
11. Berger MM, Baines M, Chioléro RL, Wardle CA, Cayeux C, Shenkin A. Influence of early trace element and vitamin E supplements on antioxidant status after major trauma: a controlled trial. Nutrition Research 2001;21:41-54.
12. Berger MM, Reymond MJ, Shenkin A, Rey F, Wardle C, Cayeux C, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Medicine 2001;27(1):91-100. [MEDLINE: PMID: 11280679]
13. Forceville X, Bellissant E. Selenium, as sodium selenite, in the treatment of septic shock. http://clinicaltrials.gov/show/NCT00207844 (accessed 8 August 2006).
14. Forceville X, Lavoille B, Annane D, Vitoux D, Bleichner G, Korach JM, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Critical Care 2007;11(4):R73.
15. Janka V, Ladislav K, Jozef F, Ladislav V. Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients. Wiener klinische Wochenschrift 2013;125(11-2):316-25. [DOI: 10.1007/s00508-013-0371-x]
16. Kuklinski B, Buchner M, Schweder R, Nagel R. Acute pancreatitis - a "free radical disease". Decrease of lethality by sodium selenite (Na2SeO3) therapy [Akute pankreatitis - eine "free radical disease". Letalitatssenkung durch natriumselenit (Na2SeO3)-therapie]. Zeitschrift für die Gesamte Innere Medizin und Ihre Grenzgebiete 1991;46(5):145-9. [MEDLINE: PMID: 1648849]
17. Lindner D, Lindner J, Baumann G, Dawczynski H, Bauch K. Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial [Untersuchung zur antioxidativen therapie mit natriumselenit bei akuter pankreatitis. Eine prospektive, randomisierte blindstudie]. Medizinische Klinik 2004;99(12):708-12. [MEDLINE: PMID: 15599680]
18. Manzanares W, Biestro A, Torre MH, Galusso F, Fachin G, Hardy G. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Medicine 2011;37(7):1120-7.
19. Mishra V, Baines M, Perry S, McLaughlin J, Carson J, Wenstone R, et al. Selenium supplementation and outcome in septic ICU patients. Clinica Chimica Acta 2005;355(Suppl 1):S45.
20. Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clinical Nutrition 2007;26(1):41-50.
21. Mishra V, Perry S, Baines M, McLaughlin J, Carson J, Wenstone R, et al. Selenium replacement, HLA-DR expression and outcome in septic ICU patients. Intensive Care Medicine 2004;30(Suppl 1):110.
22. Montoya CG, Luna AH, Silva JAV, Guzmán CO, Sánchez JA, Granillo JF. High doses of selenium in severe sepsis [Efecto antiinflamatorio del selenio en pacientes sećpticos]. Revista de la Asociación Mexicana de Medicina Crítica y Terapia Intensiva 2009;23(4):199-205.
23. Ogawa A, Yoshimoto T, Kikuchi H, Sano K, Saito I, Yamaguchi T, et al for the Ebselen Study Group. Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovascular Diseases 1999;9(2):112-8. [MEDLINE: PMID: 9973655]
24. Asano T, Takakura K, Sano K. Comparative analysis of the clinical effects of water-soluble (AVS) and -insoluble (ebselen) antioxidants on the delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases 1996;6(Suppl 1):188-92.
25. Saito I, Abe H, Yoshimoto T, Asano T, Takakura K, Ohta T, et al. Multicentre randomised clinical trial of ebselen with aneurysmal subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 1995;15(Suppl 1):162.
26. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, et al. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 1998;42(2):269-78. [MEDLINE: PMID: 9482177]
27. Andrews PJ. Randomised trial of glutamine and selenium supplemented parenteral nutrition (PN) for critically ill patients. http://www.isrctn.com/ISRCTN87144826 (accessed 21 October 2014).
28. Andrews PJ, Avenell A, Noble DW, Campbell MK, Battison CG, Croal BL, et al. Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial. Trials 2007;8:25.
29. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011;342:d1542.
30. Andrews PJ, Avenell A, and the SIGNET Trial Group. Results of The SIGNET Trial - a randomised controlled trial of glutamine and/or selenium supplemented parenteral nutrition in critical illness. Proceedings of the Nutrition Society 2010;69(OCE2):E170.
31. Andrews PJ, Simpson WG and the SIGNET Trial group. Results of the SIGNET Trial - a randomised controlled trial of glutamine and/or selenium supplemented parenteral nutrition in critical illness. Clinical Nutrition Supplements 2010;5(2):22.
32. Brodska H, Kazda A, Valenta J, Hendl J. Effect of high-dose selenium substitution on selected laboratory parameters and prognosis in critically ill patients. Critical Care 2009;13(Suppl 1):S62.
33. Brodska H, Kazda A, Valenta J, Stach Z, Hendl J, Pelinkova K. High dose of selenium in critically ill. Clinical Nutrition Supplements 2007;2(2):20-1.
34. Brodska H, Kazda A, Valenta J, Stach Z, Hendl J, Pelinkova K, et al. Laboratory monitoring during high dose selenium substitution in critically ill patients. Clinical Chemistry and Laboratory Medicine 2007;45:S396.
35. Brodska H, Kohout P, Malickova K, Kazda A, Valenta J. Influence of high selenium doses supplementation on markers of nutritional status. Clinical Nutrition Supplements 2010;5(2):115.
36. Kazda A, Brodska H, Valenta J, Vinglerova M, Hendl J, Stach Z, et al. Selenium and its substitution in critically ill patients. Critical Care 2006;10(Suppl 1):S79-80.
37. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Medicine 2011;37(5):808-15.
38. Valenta J, Brodska H, Kazda A, Stach Z, Hendl J, Pelinkova K. Effect of high-dose selenium substitution on selected laboratory parameters and prognosis in critically ill patients. Critical Care 2007;11(Suppl 2):S62.
39. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, et al for the Ebselen Study Group. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Stroke 1998;29(1):12-7. [MEDLINE: PMID: 9445321]
40. Zimmermann T, Albrecht S, Kühne H, Vogelsang U, Grützmann R, Kopprasch S. Selenium administration in patients with sepsis syndrome. A prospective randomized study [Selensubstitution bei sepsispatienten. Eine prospektiv randomisierte studie]. Medizinische Klinik 1997;92(Suppl 3):3-4. [MEDLINE: PMID: 9417494]
41. Zimmermann T, Albrecht S, von Gagern G. Molecular-biology studies of a multicenter phase III study (SIC-study) [Molekularbiologische untersuchungen zur multizentrischen phase-III-studie (SIC-studie)]. Medizinische Klinik 1999;94(Suppl 3):58-61.
42. Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 1998;68(2):365-71. [MEDLINE: PMID: 9701195]
43. Berger M, Binnert C, Baines M, Raffoul W, Cayeux M, Chiolero R, et al. Trace element supplements influence protein metabolism and tissue levels after major burns. Intensive Care Medicine 2004;30(Suppl 1):61.
44. Berger M, Soguel L, Schindler C, Revelly J, Chiolero R. Antioxidant micronutrients after complex cardiac surgery and clinical evolution? Preliminary data. Intensive Care Medicine 2004;30(Suppl 1):175.
45. Berger MM, Eggimann P, Revelly JP, Raffoul W, Shenkin A, Chiolero R. Trace element supplements are associated with fewer nosocomial pneumonia after major burns. Intensive Care Medicine 2005;31(Suppl 1):77.
46. Berger MM, Eggimann P, Revelly JP, Raffoul W, Shenkin A, Chiolero RL. Selenium supplements reduce the incidence of nosocomial pneumonia after major burns. Clinical Nutrition 2005;24:614.
47. Berger MM, Soguel L, Pinget C, Revelly JP, Schindler C, Chiolero RL. Antioxidant supplements modulate clinical course after complex cardiac surgery, and major trauma. Intensive Care Medicine 2005;31(Suppl 1):32.
48. Berger MM, Soguel L, Pinget C, Revelly JP, Schindler C, Chiolero RL. Antioxidant supplements modulate clinical course after complex cardiac surgery, major trauma, and subarachnoid haemorrhage. Clinical Nutrition 2005;24(4):616.
49. Berger M, Soguel L, Shenkin A, RevellyJP, Pinget C, Baines M, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Critical Care 2008;12(4):R101. [DOI: 10.1186/cc6981]
50. Börner J, Zimmermann T, Albrecht S, Roesner D. Selenium administration in severe inflammatory surgical diseases and burns in childhood [Selensubstitution bei schweren entzündlichen chirurgischen krankheitsbildern sowie verbrennungen un verbrühungen in kindesalter]. Medizinische Klinik 1997;92(Suppl 3):17-9. [MEDLINE: 9417488]
51. Collier BR, Giladi A, Dossett LA, Dyer L, Fleming SB, Cotton BA. Impact of high-dose antioxidants on outcomes in acutely injured patients. Journal of Parenteral and Enteral Nutrition 2008;32(4):384-8. [DOI: 10.1177/0148607108319808]
52. Kiessling AH, Isgro F, Skuras JA, Kammerer I, Lehmann A, Saggau W. Selenium application in intensive care medicine. Intensive Care Medicine 2006;32(Suppl 1):89.
53. Porter JM, Ivatury RR, Azimuddin K, Swami R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. American Surgeon 1999;65(5):478-83 (Erratum in American Surgeon 1999;65:902). [MEDLINE: 10231223]
54. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. New England Journal of Medicine 2013;368(16):1489-97. [DOI: 10.1056/NEJMoa1212722]
55. Stoppe C, Wildenhues A, Metzelder S, Schalte G, Menon AK, Rossaint R, et al. The effects of high dose selenium supplementation on perioperative systemic inflammation in patients undergoing open heart surgery. Intensive Care Medicine 2010;36(Suppl 2):S316.
56. Thiele R, Wagner D, Gassel M, Winnefeld K, Pleissner J, Pfeifer R. Selenium substitution in acute myocardial infarct [Selensubstitution bei akutem myokardinfarkt]. Medizinische Klinik 1997;92(Suppl 3):26-8. [MEDLINE: 9417492]
57. Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Alimentary Pharmacology and Therapeutics 1990;4(4):357-71. [MEDLINE: 2103755]
58. Watters JM, Vallerand A, Kirkpatrick SM, Abbott HE, Norris S, Wells G, et al. Limited effects of micronutrient supplementation on strength and physical function after abdominal aortic aneursymectomy. Clinical Nutrition 2002;21(4):321-7. [MEDLINE: 12135593]
59. Wollschläger S, Ludwig K, Meissner D, Porst H. Effect of selenium administration on various laboratory parameters in patients with acute pancreatitis [Einfluß einer selensubstitution auf verschiedene laborparameter bei patienten mit akuter pankreatitis]. Medizinische Klinik 1997;92(Suppl 3):22-4. [MEDLINE: 9417490]
60. Geoghegan M, Eaton S, Mandersloot G, Healy M, McAuley DF, Rayman MP, et al. Selenium decreases lipid peroxidation in critically-ill patients with sub-arachnoid haemorrhage. Clinical Nutrition Supplements 2009;4(2):31.
61. Yamaguchi T, for Ebselen Study Group. Phase III trial of Ebselen (abstract). American Stroke Association 28th International Stroke Conference, 2003 February 13-15; Phoenix, Arizona. 2003.
62. Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients. Ongoing study September 2012.
63. Reinhart K. Placebo controlled trial of sodium selenite and procalcitonin guided antimicrobial therapy in severe sepsis. http://clinicaltrials.gov/ct2/show/NCT00832039. [NCT00832039]
64. Angstwurm MW, Gaertner R. Practicalities of selenium supplementation in critically ill patients. Current Opinion in Clinical Nutrition and Metabolic Care 2006;9(3):233-8.
65. American Society for Parenteral and Enteral Nutrition. https://www.nutritioncare.org/(accessed 21 October 2014).
66. Berger M, Baines M, Raffoul W, Benathan M, Chiolero R, Reeves C. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. The American journal of clinical nutrition 2007;85:1293-300. [PUBMED: 17490965]
67. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98. [MEDLINE: 18824466]
68. Bulger EM, Maier RV. Antioxidants in critical illness. Archives of Surgery 2001;136(10):1201-7. [MEDLINE: PMID: 11585516]
69. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457-65. [MEDLINE: 15161896]
70. European Society for Clinical Nutrition and Metabolism. http://www.espen.org/(Accessed 21 October 2014).
71. Geoghegan M, McAuley D, Eaton, Powell-Tuck J. Selenium in critical illness. Current Opinion in Critical Care 2006;12(2):136-41.
72. Giladi A, Dossett L, Fleming S, Abumrad N, Cotton B. High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Injury 2011;42:78-82. [PUBMED: 20149369]
73. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Mediicine 2005;31(3):327-37. [MEDLINE: 15605227]
74. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [MEDLINE: 12111919]
75. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
76. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. [DOI: 10.1002/9780470712184]
77. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [PUBMED: 15840177]
78. Huang TS, Shyu YC, Chen HY, Lin LM, Lo CY, Yuan SS, et al. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One 2013;8(1):e54431. [DOI: 10.1371/journal.pone.0054431]
79. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Journal of the Royal Statistical Society Series 2000;49:359-70. [MEDLINE: 11122498]
80. Jennett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1975;1:480-4. [MEDLINE: 46957]
81. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
82. Landucci F, Mancinelli P, De Gaudio AR, Virgili G. Selenium supplementation in critically ill patients: a systematic review and meta-analysis. Journal of Critical Care 2014;29(1):150-6. [DOI: 10.1016/j.jcrc.2013.08.017]
83. Manzanares W, Hardy G. Selenium supplementation in the critically ill: posology and pharmacokinetics. Current Opinion in Clinical Nutrition and Metabolic Care 2009;12(3):273-80.
84. Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Critical Care 2012;16(2):R66. [DOI: 10.1186/cc11316.]
85. Moher D, Hopewell S, Schulz K, Montori V, Gøtzsche P, Devereaux P, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International journal of surgery 2010;10:28-55. [PUBMED: 22036893]
86. Parnham M, Sies H. Ebselen: prospective therapy for cerebral ischaemia. Expert Opinion on Investigational Drugs 2000;9(3):607-19. [MEDLINE: 11060699]
87. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis. Controlled Clinical Trials 1997;18(6):580-93. [MEDLINE: 9408720]
88. Rayman M. Selenium and human health. Lancet 2012;379:1256-68. [PUBMED: 22381456]
89. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3.5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
90. Sattar N, Eatock F, Fell GS, O'Reilly D. Selenium: an acute-phase reactant?. Annals of Clinical Biochemistry 1997;34(Pt 4):437-9. [MEDLINE: PMID: 9247681]
91. Shah S, Vanclay F, Cooper B. Predicting discharge status at commencement of stroke rehabilitation. Stroke 1989;20(6):766-9. [MEDLINE: PMID: 2728043]
92. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. International Journal of Epidemiology 2009;38(1):276-86. [MEDLINE: 18824467]
93. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). CTU (Copenhagen Trial Unit). 2011. http://www.ctu.dk/TSA/files/tsa_manual.pdf (accessed 21 Oct 2014):1-118.
94. Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark. www.ctu.dk/tsa. TSA - Trial Sequential Analysis. Copenhagen Trial Unit (CTU). Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark. www.ctu.dk/tsa, 2011.
95. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75. [MEDLINE: 18083463]
96. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. [MEDLINE: 20042080]
97. Avenell A, Noble DW, Barr J, Engelhardt T. Selenium supplementation for critically ill adults. Cochrane Database of Systematic Reviews 3, Issue 2002. [DOI: 10.1002/14651858.CD003703]
98. Avenell A, Noble DW, Barr J, Engelhardt T. Selenium supplementation for critically ill adults. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD003703.pub2]